All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...
StockNews.com upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from a hold rating to a buy rating ...
Hosted on MSN5mon
Teva pays $450 million to settle kickback scheme chargesOct. 10 (UPI) --Teva Pharmaceuticals, the largest generic drug manufacturer in the United States, has agreed to pay $450 million to resolve two claims that allege the company violated the Anti ...
Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating ...
The FDA has approved Teva’s Huntington’s Disease drug, the first new treatment for the neurological disease in almost a decade. The FDA has approved Austedo (deutetrabenazine) tablets for the ...
Hosted on MSN10mon
Teva, Alvotech launch biosimilar against AbbVie’s HumiraA U.S. unit of generic drugmaker Teva Pharmaceutical Industries (NYSE:TEVA) and Luxembourg-based Alvotech (NASDAQ:ALVO) have launched Simlandi, an interchangeable biosimilar version, targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results